New Guidelines on Bisphosphonates in Dentistry

Prof. jon

Dr. Jon Suzuki has a Presidential Appointment as Professor of Microbiology and Immunology in the School of Medicine and Professor of Periodontology and Oral Implantology in the School of Dentistry at Temple University, Philadelphia, PA. USA. He also serves as Chairman and Director of Graduate Periodontology and Oral Implantology at Temple University. He has been Dean of the School of Dental Medicine at the University of Pittsburgh and Chief of Hospital Dentistry, UPMC-Presbyterian University Hospital.

Dr. Suzuki received his D.D.S. from Loyola University of Chicago and Ph.D. in Microbiology from the Illinois Institute of Technology. He completed an N.I.H. Fellowship in Immunology at the University of Washington in Seattle, and a Clinical Certificate in Periodontics at the University of Maryland. He completed an MBA from the Katz Graduate School of Business of the University of Pittsburgh.

Dr. Suzuki is a current panel member and the immediate past-Chairman of the Food and Drug Administration Dental Products Panel, Wheaton, MD. He is on the faculty of the US Navy National Naval Medical Command, Bethesda, MD, and also holds Professorships at Nova Southeastern University, Ft. Lauderdale, FL, the University of Maryland, Baltimore, MD and Maimonides University, Buenos Aires, Argentina.

He served as Chairman of the American Dental Association Council on Scientific Affairs and continues to serve as an ADA consultant on the Scientific Council, Dental Practice Council, and the Commission on Dental Accreditation, Chicago. Dr. Suzuki served on the National Institutes of Health National Dental Advisory Research Council, and numerous NIH Study Sections in Bethesda, MD. Dr. Suzuki has hospital appointments at Temple Episcopal Hospital and the Veterans’ Affairs Medical Centers.

He is a fellow of the American and International College of Dentists, a Specialist Microbiologist of the American College of Microbiology, a Diplomate and Board Examiner of the International Congress of Oral Implantology, and a Diplomate of the American Board of Periodontology.

Dr. Suzuki is the current Executive Secretary/Treasurer of the Supreme Chapter of Omicron Kappa Upsilon, the national Honorary Dental Society, Lincoln, Nebraska, and has served in this position for over two decades.

His honors include being named “Alumnus of the Year”, Loyola University of Chicago, “Alumnus of the Year”, Illinois Wesleyan University, “Recognized Alumnus in Biological Sciences”, Illinois Institute of Technology, and “Faculty of the Year”, University of Maryland. Dr. Suzuki won 1st place, Orban Prize Competition of the American Academy of Periodontology and won 1st place in the ADA/Dentsply SCADA Table Clinic Competition.

He is in private practice limited to periodontics in Philadelphia.

Dr. Suzuki has published over 150 papers, chapters, and symposia, 200 abstracts, and 1 textbook in Medical Technology.

Bisphosphonates, oral and intravenous, play a critical role in the remodelling of bone in patients with osteoporosis and low bone density.

In addition to post-menopausal females and older males, clinical medical research has identified several additional groups at risk of osteoporosis. These include those with multiple myeloma, breast carcinoma, prostate carcinoma and gastric hyper acidity. Clinic al dental implications of bisphosphonates (now referred to as “anti resorptive agents”), are now well recognised. Oral lesions, diagnosed as “osteonecrosis of the jaw” (ONJ) have significant consequences. This lecture describes the clinical signs and symptoms of ONJ with guidelines of patient medication history of bisphosphonate use and patient risk factors. Recommendations (American Dental Association, November, 2011) and diagnosis for ONJ will be discussed. Current treatment approaches and available tests will be critically appraised and prevention strategies including drug holidays will be discussed